Glenmark Pharmaceuticals (BOM:532296) Accounts Payable & Accrued Expense : ₹26,079 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Accounts Payable & Accrued Expense?

Glenmark Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2024 (₹25,285 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹26,079 Mil).

Glenmark Pharmaceuticals's annual accounts payable & accrued expense increased from Mar. 2023 (₹23,680 Mil) to Mar. 2024 (₹31,020 Mil) but then declined from Mar. 2024 (₹31,020 Mil) to Mar. 2025 (₹26,079 Mil).

Glenmark Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Glenmark Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Accounts Payable & Accrued Expense Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

25,059.60

25,790.16

23,679.87

31,019.80

26,079.04

Glenmark Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															31,019.80	-	25,284.65	-	26,079.04

Glenmark Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Glenmark Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

GLENMARK:India

Address

B. D. Sawant Marg, Glenmark House, Chakala, Off Western Express Highway, Andheri (East), Mumbai, MH, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities. It has a business presence in different therapeutic areas such as dermatology, respiratory, oncology, diabetes, cardiovascular, and oral contraceptives among others. Geographically, it derives key revenue from India and the rest from North America, Latin America, Europe, and the rest of the world.

Glenmark Pharmaceuticals Headlines

No Headlines